PROCESS FOR PRODUCING SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINE TYPE CALCIUM ANTAGONIST

摘要

the invention du00f3zisforma oral pharmaceutical elu0151u00e1llu00edtu00e1su00e1ravonatkozik,of which 20u2013120 mg nifedipine or other di - hidropiridintu00edpusu00fa ca antagonist once daily application of the linear speed of hatu00f3anyagnulladrend releasedthe ku00e9szu00edtmu00e9nyhomogu00e9n matrix material 20 000u2013250 000 molecular weight, 2u201350 wt% of hydroxy propyl methyl cellulose, 5u201360 wt% tu00edpusu00faca dihydropyridine antagonist.the product is compatible with, and szokvu00e1nyossegu00e9danyagokat as leadu00e1sszabu00e1lyozu00f3kat, fillers, folyu00e1sszabu00e1lyozu00f3 materials, su00edkosu00edtu00f3szereket and gave esetbenfilmbevonatot contains. a